USE OF PROSTAGLANDIN F3α AS AN OCULAR HYPOTENSIVE AGENT

摘要

The invention relates to a means of reducing or maintaining intraocular pressure, and, more particularly, to a method and composition for reducing or maintaining intraocular pressure involving the administration of a composition containing prostaglandin F3α in a pharmaceutically acceptable carrier.